ABPI
GSK’s Witty: ‘Drugs should be cheaper’
March 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty
Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …
Pulse mistake costs Astellas
March 15, 2013Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse
A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …
ABPI supply chain warning
March 7, 2013Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA
The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …
ABPI moves to improve compliance
February 28, 2013Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead
The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …
Roche increases data access
February 27, 2013Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche
Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
Roche censured for drunken conference antics
February 21, 2013Medical Communications, Sales and Marketing ABPI, PMCPA, Roche
The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …
VBP negotiations ‘opened up’
February 19, 2013Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP
Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …
Lancet sparks agency row
February 15, 2013Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris
Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …
GSK announces AllTrials support
February 6, 2013Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre
GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …
GP concern over GMC guidance
February 5, 2013Sales and Marketing ABPI, GMC, GP, NHS
The ABPI has ‘warmly’ welcomed the new prescribing guidance from the General Medical Council – but GPs are far from …
NICE hits back at ‘limited’ EC study
January 28, 2013Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead
NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …
The price of innovation
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP
One of the strange paradoxes of our industry is that we have a very large number of new medicines in …
NICE publishes formulary guidance
December 19, 2012Sales and Marketing ABPI, NHS, NICE, formularies, formulary
NICE has published its first guidance on good practice for those involved in working out what medicines should be made …
Pharma applauds government strategy
December 11, 2012Sales and Marketing ABPI, BIA, Cameron, Willetts
The ABPI and BioIndustry Association (BIA) have both welcomed the government’s update on its Strategy for UK Life Sciences, launched …
Latest content
FibroFind appoints Lee Borthwick as CEO
